{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:15:30Z","timestamp":1793042130521,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37 AI062765"],"award-info":[{"award-number":["R37 AI062765"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Emerald grant 2022 to JSB and WP."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54874-y","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:41:20Z","timestamp":1733121680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Regulatory T cells crosstalk with tumor cells and endothelium through lymphotoxin signaling"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0005-3930","authenticated-orcid":false,"given":"Wenji","family":"Piao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"Zapas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Paluskievicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3783-6488","authenticated-orcid":false,"given":"Robert S.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Pettit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2147-9670","authenticated-orcid":false,"given":"Margaret L.","family":"Sleeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-270X","authenticated-orcid":false,"given":"Keli L.","family":"Hippen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2862-7302","authenticated-orcid":false,"given":"Philipp","family":"Ivanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8790-7649","authenticated-orcid":false,"given":"Amol C.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lushen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina W.","family":"Shirkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4813-8917","authenticated-orcid":false,"given":"Allison","family":"Kensiski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamna","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4816-4875","authenticated-orcid":false,"given":"Vikas","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Br\u00e4sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6668-6928","authenticated-orcid":false,"given":"Christopher M.","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9608-9841","authenticated-orcid":false,"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-8795","authenticated-orcid":false,"given":"Jonathan S.","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"54874_CR1","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1158\/0008-5472.CAN-06-0217","volume":"66","author":"M Lukashev","year":"2006","unstructured":"Lukashev, M. et al. Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy. Cancer Res. 66, 9617\u20139624 (2006).","journal-title":"Cancer Res."},{"key":"54874_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nri1151","volume":"3","author":"JL Gommerman","year":"2003","unstructured":"Gommerman, J. L. & Browning, J. L. Lymphotoxin\/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3, 642\u2013655 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"54874_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05412-0","volume":"9","author":"W Piao","year":"2018","unstructured":"Piao, W. et al. Regulation of T cell afferent lymphatic migration by targeting LTbetaR-mediated non-classical NFkappaB signaling. Nat. Commun. 9, 3020 (2018).","journal-title":"Nat. Commun."},{"key":"54874_CR4","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1038\/onc.2010.260","volume":"29","author":"MJ Wolf","year":"2010","unstructured":"Wolf, M. J., Seleznik, G. M., Zeller, N. & Heikenwalder, M. The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development. Oncogene 29, 5006\u20135018 (2010).","journal-title":"Oncogene"},{"key":"54874_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","volume":"12","author":"JJ Keats","year":"2007","unstructured":"Keats, J. J. et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12, 131\u2013144 (2007).","journal-title":"Cancer Cell"},{"key":"54874_CR6","first-page":"4034","volume":"62","author":"T Hehlgans","year":"2002","unstructured":"Hehlgans, T. et al. Lymphotoxin-beta receptor immune interaction promotes tumor growth by inducing angiogenesis. Cancer Res. 62, 4034\u20134040 (2002).","journal-title":"Cancer Res."},{"key":"54874_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ccell.2016.08.011","volume":"30","author":"H Tang","year":"2016","unstructured":"Tang, H. et al. Facilitating T cell infiltration in tumor microenvironment overcomes resistance to PD-L1 blockade. Cancer Cell 30, 500 (2016).","journal-title":"Cancer Cell"},{"key":"54874_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/carcin\/bgt014","volume":"34","author":"X Hu","year":"2013","unstructured":"Hu, X. et al. Lymphotoxin beta receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-kappaB activation. Carcinogenesis 34, 1105\u20131114 (2013).","journal-title":"Carcinogenesis"},{"key":"54874_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110447","volume":"38","author":"K Kos","year":"2022","unstructured":"Kos, K. et al. Tumor-educated T(regs) drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche. Cell Rep. 38, 110447 (2022).","journal-title":"Cell Rep."},{"key":"54874_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-cancerbio-042920-104912","volume":"5","author":"K Kos","year":"2021","unstructured":"Kos, K. & de Visser, K. E. The multifaceted role of regulatory T cells in breast cancer. Annu. Rev. Cancer Biol. 5, 291\u2013310 (2021).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"54874_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12021","volume":"7","author":"CC Brinkman","year":"2016","unstructured":"Brinkman, C. C. et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat. Commun. 7, 12021 (2016).","journal-title":"Nat. Commun."},{"key":"54874_CR12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.celrep.2019.12.083","volume":"30","author":"W Piao","year":"2020","unstructured":"Piao, W. et al. Regulatory T cells condition lymphatic endothelia for enhanced transendothelial migration. Cell Rep. 30, 1052\u20131062 e1055 (2020).","journal-title":"Cell Rep."},{"key":"54874_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1084\/jem.20121462","volume":"210","author":"L Onder","year":"2013","unstructured":"Onder, L. et al. Endothelial cell-specific lymphotoxin-beta receptor signaling is critical for lymph node and high endothelial venule formation. J. Exp. Med. 210, 465\u2013473 (2013).","journal-title":"J. Exp. Med."},{"key":"54874_CR14","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1172\/JCI3492","volume":"102","author":"Y Zhai","year":"1998","unstructured":"Zhai, Y. et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2\/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J. Clin. Invest. 102, 1142\u20131151 (1998).","journal-title":"J. Clin. Invest."},{"key":"54874_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10585-021-10120-z","volume":"39","author":"SP Leong","year":"2022","unstructured":"Leong, S. P., Naxerova, K., Keller, L., Pantel, K. & Witte, M. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels. Clin. Exp. Metastasis 39, 159\u2013179 (2022).","journal-title":"Clin. Exp. Metastasis"},{"key":"54874_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2022","unstructured":"Kohli, K., Pillarisetty, V. G. & Kim, T. S. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther. 29, 10\u201321 (2022).","journal-title":"Cancer Gene Ther."},{"key":"54874_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1172\/JCI64547","volume":"123","author":"H Yang","year":"2013","unstructured":"Yang, H. et al. Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice. J. Clin. Invest. 123, 418\u2013431 (2013).","journal-title":"J. Clin. Invest."},{"key":"54874_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","volume":"67","author":"D Grimm","year":"2020","unstructured":"Grimm, D. et al. The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol. 67, 122\u2013153 (2020).","journal-title":"Semin Cancer Biol."},{"key":"54874_CR19","first-page":"89","volume":"4","author":"H Chen","year":"2014","unstructured":"Chen, H., Xu, C., Jin, Q. & Liu, Z. S100 protein family in human cancer. Am. J. Cancer Res. 4, 89\u2013115 (2014).","journal-title":"Am. J. Cancer Res."},{"key":"54874_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","volume":"150","author":"S Acharyya","year":"2012","unstructured":"Acharyya, S. et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150, 165\u2013178 (2012).","journal-title":"Cell"},{"key":"54874_CR21","doi-asserted-by":"publisher","unstructured":"Cartier, A. & Hla, T. Sphingosine 1-phosphate: lipid signaling in pathology and therapy. Science https:\/\/doi.org\/10.1126\/science.aar5551 (2019).","DOI":"10.1126\/science.aar5551"},{"key":"54874_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01575-w","volume":"7","author":"Y Xiong","year":"2017","unstructured":"Xiong, Y. et al. A robust in vitro model for trans-lymphatic endothelial migration. Sci. Rep. 7, 1633 (2017).","journal-title":"Sci. Rep."},{"key":"54874_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0876-3","volume":"9","author":"N Wang","year":"2018","unstructured":"Wang, N. et al. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-kappaB\/SOX4 signaling. Cell Death Dis. 9, 880 (2018).","journal-title":"Cell Death Dis."},{"key":"54874_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97390-5","volume":"11","author":"M Kim","year":"2021","unstructured":"Kim, M., Choi, H. Y., Woo, J. W., Chung, Y. R. & Park, S. Y. Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast. Sci. Rep. 11, 18007 (2021).","journal-title":"Sci. Rep."},{"key":"54874_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/292376","volume":"2014","author":"D Aldinucci","year":"2014","unstructured":"Aldinucci, D. & Colombatti, A. The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014, 292376 (2014).","journal-title":"Mediators Inflamm."},{"key":"54874_CR26","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1038\/s41388-021-02017-8","volume":"40","author":"A Bolado-Carrancio","year":"2021","unstructured":"Bolado-Carrancio, A. et al. ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling. Oncogene 40, 6235\u20136247 (2021).","journal-title":"Oncogene"},{"key":"54874_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fmolb.2019.00148","volume":"6","author":"VK Pidugu","year":"2019","unstructured":"Pidugu, V. K., Pidugu, H. B., Wu, M. M., Liu, C. J. & Lee, T. C. Emerging functions of human IFIT proteins in cancer. Front. Mol. Biosci. 6, 148 (2019).","journal-title":"Front. Mol. Biosci."},{"key":"54874_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-132","volume":"13","author":"B Hong","year":"2014","unstructured":"Hong, B. et al. USP18 is crucial for IFN-gamma-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity. Mol. Cancer 13, 132 (2014).","journal-title":"Mol. Cancer"},{"key":"54874_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41392-021-00728-8","volume":"6","author":"J Kang","year":"2021","unstructured":"Kang, J. et al. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy. Signal Transduct. Target Ther. 6, 323 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"54874_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0428-8","volume":"14","author":"M Kpetemey","year":"2015","unstructured":"Kpetemey, M. et al. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Mol. Cancer 14, 156 (2015).","journal-title":"Mol. Cancer"},{"key":"54874_CR31","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1158\/0008-5472.CAN-17-3102","volume":"78","author":"S Hibino","year":"2018","unstructured":"Hibino, S. et al. Inhibition of Nr4a receptors enhances antitumor immunity by breaking Treg-mediated immune tolerance. Cancer Res. 78, 3027\u20133040 (2018).","journal-title":"Cancer Res."},{"key":"54874_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ni.2825","volume":"15","author":"A Sidibe","year":"2014","unstructured":"Sidibe, A. & Imhof, B. A. VE-cadherin phosphorylation decides: vascular permeability or diapedesis. Nat. Immunol. 15, 215\u2013217 (2014).","journal-title":"Nat. Immunol."},{"key":"54874_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1074-7613(00)80588-9","volume":"9","author":"A Futterer","year":"1998","unstructured":"Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M. H. & Pfeffer, K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9, 59\u201370 (1998).","journal-title":"Immunity"},{"key":"54874_CR34","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/jnci\/djj299","volume":"98","author":"N Young","year":"2006","unstructured":"Young, N. et al. Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development. J. Natl Cancer Inst. 98, 1060\u20131067 (2006).","journal-title":"J. Natl Cancer Inst."},{"key":"54874_CR35","doi-asserted-by":"publisher","unstructured":"Ando, T. et al. Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI153626 (2022).","DOI":"10.1172\/JCI153626"},{"key":"54874_CR36","first-page":"1383","volume":"16","author":"M Olbromski","year":"2018","unstructured":"Olbromski, M., Podhorska-Okolow, M. & Dziegiel, P. Role of the SOX18 protein in neoplastic processes. Oncol. Lett. 16, 1383\u20131389 (2018).","journal-title":"Oncol. Lett."},{"key":"54874_CR37","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1002\/cncr.22282","volume":"107","author":"RP Petersen","year":"2006","unstructured":"Petersen, R. P. et al. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107, 2866\u20132872 (2006).","journal-title":"Cancer"},{"key":"54874_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2019.07.017","volume":"65","author":"R Saleh","year":"2020","unstructured":"Saleh, R. & Elkord, E. Acquired resistance to cancer immunotherapy: role of tumor-mediated immunosuppression. Semin Cancer Biol. 65, 13\u201327 (2020).","journal-title":"Semin Cancer Biol."},{"key":"54874_CR39","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.jid.2021.01.027","volume":"141","author":"S Ring","year":"2021","unstructured":"Ring, S. et al. Regulatory T cells prevent neutrophilic infiltration of skin during contact hypersensitivity reactions by strengthening the endothelial barrier. J. Invest. Dermatol. 141, 2006\u20132017 (2021).","journal-title":"J. Invest. Dermatol."},{"key":"54874_CR40","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41591-021-01244-6","volume":"27","author":"MX He","year":"2021","unstructured":"He, M. X. et al. Transcriptional mediators of treatment resistance in lethal prostate cancer. Nat. Med. 27, 426\u2013433 (2021).","journal-title":"Nat. Med."},{"key":"54874_CR41","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"54874_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00885-z","volume":"13","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis. Genome Med. 13, 81 (2021).","journal-title":"Genome Med."},{"key":"54874_CR43","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis, R. et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50, 1317\u20131334 e1310 (2019).","journal-title":"Immunity"},{"key":"54874_CR44","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/ijc.25456","volume":"128","author":"B Daller","year":"2011","unstructured":"Daller, B. et al. Lymphotoxin-beta receptor activation by lymphotoxin-alpha(1)beta(2) and LIGHT promotes tumor growth in an NFkappaB-dependent manner. Int. J. Cancer 128, 1363\u20131370 (2011).","journal-title":"Int. J. Cancer"},{"key":"54874_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/mc.22938","volume":"58","author":"R Das","year":"2019","unstructured":"Das, R. et al. Lymphotoxin-beta receptor-NIK signaling induces alternative RELB\/NF-kappaB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. Mol. Carcinog. 58, 411\u2013425 (2019).","journal-title":"Mol. Carcinog."},{"key":"54874_CR46","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1158\/0008-5472.CAN-11-4026","volume":"72","author":"T Duong","year":"2012","unstructured":"Duong, T. et al. Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice. Cancer Res. 72, 3105\u20133114 (2012).","journal-title":"Cancer Res."},{"key":"54874_CR47","doi-asserted-by":"publisher","unstructured":"Overman, J. et al. Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice. Elife https:\/\/doi.org\/10.7554\/eLife.21221 (2017).","DOI":"10.7554\/eLife.21221"},{"key":"54874_CR48","doi-asserted-by":"publisher","first-page":"237ra267","DOI":"10.1126\/scitranslmed.3007974","volume":"6","author":"SL Highfill","year":"2014","unstructured":"Highfill, S. L. et al. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Sci. Transl. Med. 6, 237ra267 (2014).","journal-title":"Sci. Transl. Med."},{"key":"54874_CR49","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","volume":"56","author":"MA Moreno Ayala","year":"2023","unstructured":"Moreno Ayala, M. A. et al. CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8(+) T cell antitumor immunity. Immunity 56, 1613\u20131630 e1615 (2023).","journal-title":"Immunity"},{"key":"54874_CR50","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga, A. J., Chow, M. T. & Luster, A. D. Chemokines and the immune response to cancer. Immunity 54, 859\u2013874 (2021).","journal-title":"Immunity"},{"key":"54874_CR51","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3389\/fonc.2019.00868","volume":"9","author":"PP Kushwaha","year":"2019","unstructured":"Kushwaha, P. P., Gupta, S., Singh, A. K. & Kumar, S. Emerging role of migration and invasion enhancer 1 (MIEN1) in cancer progression and metastasis. Front. Oncol. 9, 868 (2019).","journal-title":"Front. Oncol."},{"key":"54874_CR52","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1016\/j.molcel.2021.09.016","volume":"81","author":"H Guo","year":"2021","unstructured":"Guo, H. et al. NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer. Mol. Cell 81, 4041\u20134058 e4015 (2021).","journal-title":"Mol. Cell"},{"key":"54874_CR53","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3389\/fonc.2020.01730","volume":"10","author":"C Li","year":"2020","unstructured":"Li, C. et al. RPL21 siRNA blocks proliferation in pancreatic cancer cells by inhibiting DNA replication and inducing G1 arrest and apoptosis. Front. Oncol. 10, 1730 (2020).","journal-title":"Front. Oncol."},{"key":"54874_CR54","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1600-6143.2011.03558.x","volume":"11","author":"KL Hippen","year":"2011","unstructured":"Hippen, K. L. et al. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am. J. Transpl. 11, 1148\u20131157 (2011).","journal-title":"Am. J. Transpl."},{"key":"54874_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aap9331","volume":"361","author":"F Zhang","year":"2018","unstructured":"Zhang, F. et al. Lacteal junction zippering protects against diet-induced obesity. Science 361, 599\u2013603 (2018).","journal-title":"Science"},{"key":"54874_CR56","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","volume":"375","author":"RL Grossman","year":"2016","unstructured":"Grossman, R. L. et al. Toward a shared vision for cancer genomic data. N. Engl. J. Med. 375, 1109\u20131112 (2016).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54874-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54874-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54874-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T07:03:27Z","timestamp":1733123007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54874-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54874"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54874-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.01.616077","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.S.B., W.P., and X.Y. are inventors on a patent related to LT\u03b2R antagonists entitled \u201cInhibitors of LT\u03b2R-NF\u03baB signaling pathways for treating inflammation and cancer\u201d (Patent number: 11590202). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10468"}}